+ Follow AMLODIPINE Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 1341767
[Title] => Mabisang gamot sa high blood
[Summary] => MAY gamot para sa altapresyon o high blood pressure na mabisa at mura pa. Ang tinutukoy ko ay ang Amlodipine.
[DatePublished] => 2014-07-03 00:00:00
[ColumnID] => 134020
[Focus] => 0
[AuthorID] => 1805275
[AuthorName] => Dr. Willie T. Ong
[SectionName] => PSN Opinyon
[SectionUrl] => opinyon
[URL] =>
)
[1] => Array
(
[ArticleID] => 775310
[Title] => Int'l webcast on enhancing blood pressure control held
[Summary] => At least two-thirds of patients do not achieve guideline-recommended blood pressure (BP) targets, often due to poor treatment adherence. Moreover, most patients with hypertension require two or more blood pressure-lowering drugs to achieve BP goals.
[DatePublished] => 2012-02-09 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[2] => Array
(
[ArticleID] => 537729
[Title] => Learning the ABCs of high blood pressure
[Summary] => It is true that an occasional rise in blood pressure (BP), say during heavy exercise or extreme stress, usually does not warrant a label of hypertension.
[DatePublished] => 2010-01-05 00:00:00
[ColumnID] => 134789
[Focus] => 0
[AuthorID] => 1805275
[AuthorName] => Dr. Willie T. Ong
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[3] => Array
(
[ArticleID] => 530642
[Title] => Ayaw uminom ng Amlodipine, na-stroke!
[Summary] => SA mga taong may altapresyon o diabetes, isa lang po ang aking hiling: Inumin ninyo ang maintenance na gamot sa altapresyon. Sa ganitong paraan, siguradong hahaba ang inyong buhay at hindi kayo ma-o-ospital.
[DatePublished] => 2009-12-10 00:00:00
[ColumnID] => 134020
[Focus] => 0
[AuthorID] => 1805275
[AuthorName] => Dr. Willie T. Ong
[SectionName] => PSN Opinyon
[SectionUrl] => opinyon
[URL] =>
)
[4] => Array
(
[ArticleID] => 414032
[Title] => Good news for 'high blood' patients
[Summary] => Tired of your expensive drugs for high blood pressure? Tired of spending your hard-earned money for maintenance medicines? Don’t worry for I’ve found affordable and excellent drugs to control your blood pressure.
[DatePublished] => 2008-11-11 00:00:00
[ColumnID] => 134789
[Focus] => 0
[AuthorID] => 1805275
[AuthorName] => Dr. Willie T. Ong
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[5] => Array
(
[ArticleID] => 412800
[Title] => Amvasc BE: Pinakamabisang gamot sa altapresyon
[Summary] => GOOD news kaibigan! May bagong labas na gamot para sa altapresyon na mabisa at mura pa. Ang tinutukoy ko ay ang Amvasc ...
[DatePublished] => 2008-11-06 00:00:00
[ColumnID] => 134020
[Focus] => 0
[AuthorID] => 1805275
[AuthorName] => Dr. Willie T. Ong
[SectionName] => PSN Opinyon
[SectionUrl] => opinyon
[URL] =>
)
[6] => Array
(
[ArticleID] => 373781
[Title] => Government, private sector unite for more affordable medicines
[Summary] =>
In support of government programs to lower the cost of drugs and President Arroyo’s 10-point agenda for economic recovery, Therapharma Inc., a division of United Laboratories (Unilab), recently launched an affordable and effective brand of amlodipine.
The new amlodipine is being sold at P17.50, or 60 percent more affordable than the prevailing price of the originator brand, which sells at P44.75.
This move by Therapharma is an answer to the government’s call to make effective medicines more affordable for more Filipinos.
[DatePublished] => 2006-12-07 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[7] => Array
(
[ArticleID] => 362584
[Title] => Hypertension drug gets BFAD approval
[Summary] => It’s now official. A new brand of amlodipine camsylate will soon be available in the market, courtesy of Therapharma Inc, a division of United Laboratories (Unilab).
The Bureau of Food and Drugs recently granted a certificate of product registration for the new brand of amlodipine.
The BFAD conducted a stringent evaluation of all documents and samples of the new brand of amlodipine to assess its efficacy and safety and the issuance of its certificate of product registration indicates that it has passed all tests for efficacy and safety.
[DatePublished] => 2006-10-12 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[8] => Array
(
[ArticleID] => 360233
[Title] => Treatment cost a major barrier in hypertension management
[Summary] => One of the major constraints for controlling hypertension is the limitation of resources for health care, reports the World Health Organization.
This is particularly true in low- and middle-income countries such as the Philippines, which contribute to 80 percent of the global cardiovascular burden.
[DatePublished] => 2006-09-28 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
AMLODIPINE
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 1341767
[Title] => Mabisang gamot sa high blood
[Summary] => MAY gamot para sa altapresyon o high blood pressure na mabisa at mura pa. Ang tinutukoy ko ay ang Amlodipine.
[DatePublished] => 2014-07-03 00:00:00
[ColumnID] => 134020
[Focus] => 0
[AuthorID] => 1805275
[AuthorName] => Dr. Willie T. Ong
[SectionName] => PSN Opinyon
[SectionUrl] => opinyon
[URL] =>
)
[1] => Array
(
[ArticleID] => 775310
[Title] => Int'l webcast on enhancing blood pressure control held
[Summary] => At least two-thirds of patients do not achieve guideline-recommended blood pressure (BP) targets, often due to poor treatment adherence. Moreover, most patients with hypertension require two or more blood pressure-lowering drugs to achieve BP goals.
[DatePublished] => 2012-02-09 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[2] => Array
(
[ArticleID] => 537729
[Title] => Learning the ABCs of high blood pressure
[Summary] => It is true that an occasional rise in blood pressure (BP), say during heavy exercise or extreme stress, usually does not warrant a label of hypertension.
[DatePublished] => 2010-01-05 00:00:00
[ColumnID] => 134789
[Focus] => 0
[AuthorID] => 1805275
[AuthorName] => Dr. Willie T. Ong
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[3] => Array
(
[ArticleID] => 530642
[Title] => Ayaw uminom ng Amlodipine, na-stroke!
[Summary] => SA mga taong may altapresyon o diabetes, isa lang po ang aking hiling: Inumin ninyo ang maintenance na gamot sa altapresyon. Sa ganitong paraan, siguradong hahaba ang inyong buhay at hindi kayo ma-o-ospital.
[DatePublished] => 2009-12-10 00:00:00
[ColumnID] => 134020
[Focus] => 0
[AuthorID] => 1805275
[AuthorName] => Dr. Willie T. Ong
[SectionName] => PSN Opinyon
[SectionUrl] => opinyon
[URL] =>
)
[4] => Array
(
[ArticleID] => 414032
[Title] => Good news for 'high blood' patients
[Summary] => Tired of your expensive drugs for high blood pressure? Tired of spending your hard-earned money for maintenance medicines? Don’t worry for I’ve found affordable and excellent drugs to control your blood pressure.
[DatePublished] => 2008-11-11 00:00:00
[ColumnID] => 134789
[Focus] => 0
[AuthorID] => 1805275
[AuthorName] => Dr. Willie T. Ong
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[5] => Array
(
[ArticleID] => 412800
[Title] => Amvasc BE: Pinakamabisang gamot sa altapresyon
[Summary] => GOOD news kaibigan! May bagong labas na gamot para sa altapresyon na mabisa at mura pa. Ang tinutukoy ko ay ang Amvasc ...
[DatePublished] => 2008-11-06 00:00:00
[ColumnID] => 134020
[Focus] => 0
[AuthorID] => 1805275
[AuthorName] => Dr. Willie T. Ong
[SectionName] => PSN Opinyon
[SectionUrl] => opinyon
[URL] =>
)
[6] => Array
(
[ArticleID] => 373781
[Title] => Government, private sector unite for more affordable medicines
[Summary] =>
In support of government programs to lower the cost of drugs and President Arroyo’s 10-point agenda for economic recovery, Therapharma Inc., a division of United Laboratories (Unilab), recently launched an affordable and effective brand of amlodipine.
The new amlodipine is being sold at P17.50, or 60 percent more affordable than the prevailing price of the originator brand, which sells at P44.75.
This move by Therapharma is an answer to the government’s call to make effective medicines more affordable for more Filipinos.
[DatePublished] => 2006-12-07 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[7] => Array
(
[ArticleID] => 362584
[Title] => Hypertension drug gets BFAD approval
[Summary] => It’s now official. A new brand of amlodipine camsylate will soon be available in the market, courtesy of Therapharma Inc, a division of United Laboratories (Unilab).
The Bureau of Food and Drugs recently granted a certificate of product registration for the new brand of amlodipine.
The BFAD conducted a stringent evaluation of all documents and samples of the new brand of amlodipine to assess its efficacy and safety and the issuance of its certificate of product registration indicates that it has passed all tests for efficacy and safety.
[DatePublished] => 2006-10-12 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[8] => Array
(
[ArticleID] => 360233
[Title] => Treatment cost a major barrier in hypertension management
[Summary] => One of the major constraints for controlling hypertension is the limitation of resources for health care, reports the World Health Organization.
This is particularly true in low- and middle-income countries such as the Philippines, which contribute to 80 percent of the global cardiovascular burden.
[DatePublished] => 2006-09-28 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
abtest
February 9, 2012 - 12:00am
December 7, 2006 - 12:00am
October 12, 2006 - 12:00am
September 28, 2006 - 12:00am
